LENZ Therapeutics, Inc. (LENZ)
6.58
-0.21
(-3.09%)
USD |
NASDAQ |
Jun 10, 16:00
6.58
0.00 (0.00%)
After-Hours: 20:00
LENZ Therapeutics SG&A Expense (Quarterly) : 44.96M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 44.96M |
| December 31, 2025 | 39.63M |
| September 30, 2025 | 27.60M |
| June 30, 2025 | 12.80M |
| March 31, 2025 | 11.11M |
| December 31, 2024 | 9.357M |
| September 30, 2024 | 6.494M |
| June 30, 2024 | 7.407M |
| March 31, 2024 | 5.551M |
| December 31, 2023 | 14.60M |
| September 30, 2023 | 2.861M |
| June 30, 2023 | 2.32M |
| March 31, 2023 | 2.291M |
| Date | Value |
|---|---|
| December 31, 2022 | 8.289M |
| September 30, 2022 | 7.852M |
| June 30, 2022 | 8.999M |
| March 31, 2022 | 7.712M |
| December 31, 2021 | 7.735M |
| September 30, 2021 | 5.919M |
| June 30, 2021 | 4.866M |
| March 31, 2021 | 3.991M |
| December 31, 2020 | 1.933M |
| September 30, 2020 | 1.454M |
| June 30, 2020 | 0.869M |
| March 31, 2020 | 0.121M |
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 36.58M |
| NRX Pharmaceuticals, Inc. | 3.813M |
| ANI Pharmaceuticals, Inc. | 73.66M |
| Corcept Therapeutics, Inc. | 145.36M |
| Assertio Holdings, Inc. | 11.14M |